Stock VIGL VIGIL NEUROSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Vigil Neuroscience, Inc.

Equities

VIGL

US92673K1088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
2.58 USD -6.86% Intraday chart for Vigil Neuroscience, Inc. -6.18% -23.67%
Apr. 17 Vigil Neuroscience, Inc. Presents Key Findings from Illuminate & Ignite Studies in ALSP At the 2024 American Academy of Neurology Annual Meeting CI
Mar. 26 Wedbush Trims Vigil Neuroscience Price Target to $22 From $23, Maintains Outperform Rating MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
GL
Vigil Neuroscience, Inc. Presents Key Findings from Illuminate & Ignite Studies in ALSP At the 2024 American Academy of Neurology Annual Meeting
CI
Wedbush Trims Vigil Neuroscience Price Target to $22 From $23, Maintains Outperform Rating
MT
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GL
Vigil Neuroscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Vigil Neuroscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
North American Morning Briefing : Markets Steady -2-
DJ
Vigil Neuroscience Names Petra Kaufmann Chief Medical Officer
MT
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
GL
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
AQ
Vigil Neuroscience, Inc. Announces Executive Changes
CI
North American Morning Briefing : Stock Futures -2-
DJ
Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting
GL
Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting
AQ
Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days
GL
Vigil Announces Oral Presentation on Small Molecule TREM2 Agonist VG-3927 as a Potential Disease-Modifying Therapeutic at AD/PD 2024
GL
Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024
GL
Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024
AQ
Vigil Neuroscience to Present at Guggenheim 6th Annual Biotechnology Conference
GL
Transcript : Vigil Neuroscience, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 07:30 AM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VIGL Stock
  4. News Vigil Neuroscience, Inc.